A Study to Test Whether Spesolimab Helps People With a Skin Disease Called Netherton Syndrome
Clinical trial NCT05856526 · TERMINATED
Trial details
- NCT number
- NCT05856526
- Sponsor
- Boehringer Ingelheim
- Status
- TERMINATED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-06-12
- Primary completion
- 2025-01-13
- Enrollment
- 43
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.